Genetic mutation in some East Asians linked to aldehyde storm and increased liver disease risk
Researchers have identified the mechanism by which a common genetic mutation increases liver disease risk. Their findings suggest…
Study identifies C1orf122 as prognostic marker in liver cancer
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for…
Citrus flavonoid hesperidin lowers oxidative damage in cell experiments
A citrus-derived flavonoid shows potent antioxidant and anti-inflammatory effects in immune cells, hinting at future therapeutic potential. Study:…
Scientists uncover brain circuit that turns cravings into eating behavior
Scientists uncovered how the brain’s bed nucleus of the stria terminalis acts as a master switchboard, merging reward…
RAB26 identified as a critical regulator of prostate cancer aggressiveness
Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has…
New method reveals how mitochondrial DNA mutations influence cancer growth
Mitochondria act as energy factories in cells and have their own, separate DNA. Mutations to mitochondrial DNA (mtDNA)…
Rare ABCA7 gene variants linked to Alzheimer’s risk
A new study from MIT neuroscientists reveals how rare variants of a gene called ABCA7 may contribute to…
Nanobody-based strategy targets survivin to weaken cancer cells
Cancer cells have many strategies for resisting therapy. One such strategy is survivin, a protein that drives the…
Rapid neuronal evolution linked to high prevalence of autism in humans
A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that the relatively high…
New feedback mechanism in the brain could open avenues for treating people with sleep disorders
As every bodybuilder knows, a deep, restful sleep boosts levels of growth hormone to build strong muscle and…
Cancer cells found to use ketones as alternate fuel for growth
When it comes to their survival, cancer cells have a host of backup plans. This is especially true…
Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…